Hilal Lashuel is an assistant professor of neuroscience at the Integrative Biosciences Institute, Ecole Polytechnique Fédérale de Lausanne (EPFL) in Lausanne, Switzerland and the director of the laboratory of molecular neurobiology and functional neuroproteomics. He received his B.Sc degree in chemistry from the City University of New York in 1994 and completed his doctoral studies at Texas A&M University and the Scripps Research Institute in 1999. From 2000-2001 he worked as a research scientist at the Picower Institute for Medical Research in Long Island, N.Y., where he focused on developing amyloid-based therapeutic strategies for Alzheimer's disease.

In 2001, he moved to Harvard Medical School and the Brigham and Women's Hospital as a research fellow in the Center for Neurologic Diseases. In 2002, he received a sabbatical fellowship from Harvard Center for Neurodegeneration and Repair. In 2002, he was promoted to instructor in neurology at Harvard Medical School and the Brigham and Women's Hospital. Lashuel's current research interests are focused on elucidating the structural basis of amyloid associated toxicity with the aim of developing mechanism-based therapeutic strategies for treating neurodegenerative diseases, including Alzheimer's, Parkinson's, and Huntington's disease; understanding the role of quaternary structure in protein function and disease; and exploiting amyloid fibril formation for constructing polypeptide materials with potential applications in biotechnology and medicine.

During the last 6 years, he has published more than 30 novel findings in highly reputable scientific journals, including Cell, Nature and Neuron, and several book chapters. In addition, he serves as a peer reviewer for many scientific journals and funding agencies and has been invited to speak and present his work in several national and international scientific conferences (http://nmnf.epfl.ch/page9209.html). Prof. Lashuel can be reached by e-mail at hilal.lashuel@epfl.ch.